{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T00:28:34Z","timestamp":1783988914862,"version":"3.55.0"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100006606","name":"Natural Science Foundation of Tianjin City","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006606","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.msard.2021.102774","type":"journal-article","created":{"date-parts":[[2021,1,19]],"date-time":"2021-01-19T01:10:02Z","timestamp":1611018602000},"page":"102774","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Elevated cerebrospinal fluid \u03b22-microglobulin levels in patients with neuromyelitis optica spectrum disorders"],"prefix":"10.1016","volume":"49","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6100-4115","authenticated-orcid":false,"given":"Lin-Jie","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Qi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng-Hui","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen-Na","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiu-Xia","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Sha","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1974-4216","authenticated-orcid":false,"given":"Chun-Sheng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2716-3793","authenticated-orcid":false,"given":"Li","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.msard.2021.102774_bib0001","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.1468-1331.2004.00808.x","article-title":"beta2-microglobulin serum level is not a marker of disease activity in multiple sclerosis","volume":"11","author":"Bagnato","year":"2004","journal-title":"Eur J Neurol"},{"issue":"14","key":"10.1016\/j.msard.2021.102774_bib0002","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1177\/0961203314547797","article-title":"Urine beta2-microglobulin is associated with clinical disease activity and renal involvement in female patients with systemic lupus erythematosus","volume":"23","author":"Choe","year":"2014","journal-title":"Lupus"},{"issue":"6","key":"10.1016\/j.msard.2021.102774_bib0003","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1080\/1354750X.2018.1468825","article-title":"Comparison of beta2-microglobulin serum level between Alzheimer's patients, cognitive healthy and mild cognitive impaired individuals","volume":"23","author":"Dominici","year":"2018","journal-title":"Biomarkers"},{"issue":"3","key":"10.1016\/j.msard.2021.102774_bib0004","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1097\/WCO.0000000000000694","article-title":"Neuromyelitis optica spectrum disorders: still evolving and broadening","volume":"32","author":"Fujihara","year":"2019","journal-title":"Curr Opin Neurol"},{"issue":"4","key":"10.1016\/j.msard.2021.102774_bib0005","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1093\/ndt\/gfn623","article-title":"beta2-Microglobulin is potentially neurotoxic, but the blood brain barrier is likely to protect the brain from its toxicity","volume":"24","author":"Giorgetti","year":"2009","journal-title":"Nephrol Dial Transplant"},{"issue":"8","key":"10.1016\/j.msard.2021.102774_bib0006","doi-asserted-by":"crossref","first-page":"3058","DOI":"10.1182\/blood-2002-09-2924","article-title":"Regulation of human beta 2-microglobulin transactivation in hematopoietic cells","volume":"101","author":"Gobin","year":"2003","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.msard.2021.102774_bib0007","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1136\/ard.2004.030643","article-title":"Correlation of serum B lymphocyte stimulator and beta2 microglobulin with autoantibody secretion and systemic involvement in primary Sjogren's syndrome","volume":"64","author":"Gottenberg","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.msard.2021.102774_bib0008","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jneuroim.2018.07.001","article-title":"Age-adjusted CSF beta2-microglobulin and lactate are increased and ACE is decreased in patients with multiple sclerosis, but only lactate correlates with clinical disease duration and severity","volume":"323","author":"Haarmann","year":"2018","journal-title":"J Neuroimmunol"},{"issue":"10","key":"10.1016\/j.msard.2021.102774_bib0009","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1177\/0961203312447668","article-title":"Increased serum beta2-microglobulin is associated with clinical and immunological markers of disease activity in systemic lupus erythematosus patients","volume":"21","author":"Hermansen","year":"2012","journal-title":"Lupus"},{"issue":"1","key":"10.1016\/j.msard.2021.102774_bib0010","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1750-3639.2004.tb00496.x","article-title":"Expression of major histocompatibility complex class I molecules on the different cell types in multiple sclerosis lesions","volume":"14","author":"Hoftberger","year":"2004","journal-title":"Brain Pathol"},{"issue":"1-2","key":"10.1016\/j.msard.2021.102774_bib0011","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jns.2011.03.038","article-title":"Cerebrospinal fluid findings in aquaporin-4 antibody positive neuromyelitis optica: results from 211 lumbar punctures","volume":"306","author":"Jarius","year":"2011","journal-title":"J Neurol Sci"},{"issue":"6","key":"10.1016\/j.msard.2021.102774_bib0012","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/j.mehy.2013.10.011","article-title":"Aquaporin-4 antibodies, CNS acidosis and neuromyelitis optica: a potential link","volume":"81","author":"Jarius","year":"2013","journal-title":"Med Hypotheses"},{"issue":"4","key":"10.1016\/j.msard.2021.102774_bib0013","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1097\/MAJ.0b013e3181d26dfb","article-title":"Beta 2-microglobulin can be a disease activity marker in systemic lupus erythematosus","volume":"339","author":"Kim","year":"2010","journal-title":"Am J Med Sci"},{"issue":"24","key":"10.1016\/j.msard.2021.102774_bib0014","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1056\/NEJM197512112932404","article-title":"Beta2 microglobulin and lymphocytic infiltration in Sjogren's syndrome","volume":"293","author":"Michalski","year":"1975","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.msard.2021.102774_bib0015","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1038\/nrneurol.2014.141","article-title":"Treatment of neuromyelitis optica: state-of-the-art and emerging therapies","volume":"10","author":"Papadopoulos","year":"2014","journal-title":"Nat Rev Neurol"},{"issue":"6","key":"10.1016\/j.msard.2021.102774_bib0016","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S1474-4422(12)70133-3","article-title":"Aquaporin 4 and neuromyelitis optica","volume":"11","author":"Papadopoulos","year":"2012","journal-title":"Lancet Neurol"},{"issue":"1","key":"10.1016\/j.msard.2021.102774_bib0017","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/eji.201646477","article-title":"Lactate at the crossroads of metabolism, inflammation, and autoimmunity","volume":"47","author":"Pucino","year":"2017","journal-title":"Eur J Immunol"},{"issue":"6","key":"10.1016\/j.msard.2021.102774_bib0018","first-page":"381","article-title":"Distribution of beta2-microglobulin in cerebrospinal fluid and in cystic fluid of brain tumors. A preliminary study","volume":"26","author":"Schaub","year":"1978","journal-title":"Pathol Biol (Paris)"},{"key":"10.1016\/j.msard.2021.102774_bib0019","article-title":"Beta2-microglobulin as a diagnostic marker in cerebrospinal fluid: a follow-up study","author":"Svatonova","year":"2014","journal-title":"Dis Markers"},{"key":"10.1016\/j.msard.2021.102774_bib0020","article-title":"Cerebrospinal fluid lactate level in aquaporin-4 antibody positive neuromyelitis optica spectrum disorders: a hint on differential diagnosis and possible immunopathogenesis","volume":"47","author":"Wang","year":"2020","journal-title":"Mult Scler Relat Disord"},{"issue":"2","key":"10.1016\/j.msard.2021.102774_bib0021","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","article-title":"International consensus diagnostic criteria for neuromyelitis optica spectrum disorders","volume":"85","author":"Wingerchuk","year":"2015","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.msard.2021.102774_bib0022","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/cns.12156","article-title":"Clinical features and sera anti-aquaporin 4 antibody positivity in patients with demyelinating disorders of the central nervous system from Tianjin","volume":"20","author":"Yang","year":"2014","journal-title":"CNS Neurosci Ther"},{"issue":"3","key":"10.1016\/j.msard.2021.102774_bib0023","doi-asserted-by":"crossref","first-page":"379","DOI":"10.17219\/acem\/68291","article-title":"beta2-microglobulin as a marker of systemic lupus erythematosus activity","volume":"27","author":"Zychowska","year":"2018","journal-title":"Adv Clin Exp Med"}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034821000407?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034821000407?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T08:57:30Z","timestamp":1761901050000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034821000407"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":23,"alternative-id":["S2211034821000407"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2021.102774","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Elevated cerebrospinal fluid \u03b22-microglobulin levels in patients with neuromyelitis optica spectrum disorders","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2021.102774","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102774"}}